New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

XHEvsARKGETF Comparison

ETF 1
XHE

SPDR S&P Health Care Equipment ETF

This fund is part of
US Health Care
-0.51%
Full XHE fund page
VS
ETF 2
ARKG

ARK Genomic Revolution ETF

This fund is part of
BioTech & Genomics
-0.26%
Full ARKG fund page

SPDR S&P Health Care Equipment ETF (XHE) belongs to the US Health Care segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. XHE is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.75% for ARKG. XHE is down -7.18% year-to-date (YTD) with -$4M in YTD flows. ARKG performs better with -1.38% YTD performance, and -$16M in YTD flows. Run a side-by-side ETF comparison of XHE and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XHE vs ARKG performance and flow charts

Performance

-4.0-2.00.02.04.06.0%Feb 9Feb 17Feb 24Mar 3Mar 10

Cumulative Flows

-80 M-60 M-40 M-20 M0 M20 M40 MFeb 9Feb 17Feb 24Mar 3Mar 10

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/10/2026
1M3MYTD1Y3Y5Y
Perf.
XHE
ARKG
-5.57%-1.00%
-8.58%-6.62%
-7.18%-1.38%
-2.13%+31.18%
-6.66%+0.39%
-30.59%-67.04%
Flows
XHE
ARKG
--$82M
-$4M-$67M
-$4M-$16M
-$44M-$207M
-$295M-$614M
-$430M-$2.74B
Volatility and drawdown
3M1Y3Y5Y
Volatility
XHE
ARKG
+18.92%+38.80%
+23.53%+44.65%
+21.08%+42.34%
+24.18%+45.24%
Max drawdown
XHE
ARKG
-12.38%-19.50%
-14.34%-23.94%
-32.63%-51.98%
-49.90%-80.33%
Max drawdown duration
XHE
ARKG
61d46d
241d77d
1052d964d
1650d1820d
Trading data

Create an account to view trading data

Join for free
XHE
ARKG
Last sale
3/11/2026 at 1:30 PM
$82.04
$27.67
Previous close
03/10/2026
$81.73
$27.93
Consolidated volume
03/10/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

ARKG
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
XHE
ARKG
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/11/2026 at 1:30 PM
Live
Closed
XHE
ARKG
Last price
$82.04
$27.67
1D performance
+0.38%
-0.93%
AuM$139.06 M$1.14 B
E/R0.35%0.75%
Characteristics
XHE
ARKG
Management strategyPassiveActive
ProviderSPDRArk Investment
BenchmarkS&P Health Care Equipment Select Industry Index-
N° of holdings6130
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 26, 2011April 2, 2019
ESGNoNo
Advertisement
Exposure

Countries

XHE
USA
92.71%
Other
7.29%
ARKG
USA
73.95%
Switzerland
8.01%
Other
18.04%

Sectors

XHE
Health Care
93.87%
Other
6.13%
ARKG
Health Care
80.46%
Other
19.54%

Diversification

XHE

Total weight of top 15 holdings out of 15

30.47%
ARKG

Total weight of top 15 holdings out of 15

63.79%

Top 15 holdings

Data as of January 31, 2026
XHE
NEOGEN
2.63%
INTEGER HOLDINGS
2.17%
PENUMBRA
2.12%
UFP TECHNOLOGY
2.11%
AXOGEN
2.09%
OMNICELL
1.98%
LANTHEUS HOLDINGS
1.98%
BAXTER INTL
1.98%
GLAUKOS
1.97%
DEXCOM
1.94%
DENTSPLY SIRONA
1.92%
BUTTERFLY NETWORK INC
1.92%
ENVISTA HOLDINGS CORP
1.91%
STRYKER
1.88%
GLOBUS MEDICAL
1.86%
ARKG
CRISPR THERAPEUTICS
8.01%
PERSONALIS INC
6.15%
GUARDANT HEALTH INC
6.00%
10X GENOMICS INC
5.23%
BEAM THERAPEUTICS
4.81%
ILLUMINA
4.53%
NATERA
4.31%
RECURSION PHARMACEUTICALS
4.01%
CAREDX INC/D
3.44%
VERACYTE INC/D
3.29%
ADAPTIVE BIOTECHNOLOGIES
3.13%
INTELLIA THERAPEUTICS INC
3.10%
ABSCI
2.83%
IONIS PHARMACEUTICALS INC
2.62%
SCHRODINGER
2.33%
Frequently asked questions about XHE and ARKG

How have the XHE and ARKG ETFs performed in 2026?

As of March 10, 2026, XHE is down -7.18% year-to-date (YTD), while ARKG has lost -1.38%. That puts ARKG better performer ahead so far this year.

Which ETF is attracting more investor money: XHE or ARKG?

Year-to-date, the XHE ETF saw -$4M in flows, compared to -$16M for ARKG.

Which ETF is more volatile: XHE or ARKG?

Over the past year, XHE had a volatility of 23.53%, while ARKG experienced 44.65%.

Which ETF is bigger: XHE or ARKG?

As of March 10, 2026, XHE holds $139.06 M in assets under management (AUM), while ARKG manages $1.14 B.

What sectors do the XHE and ARKG ETFs invest in?

XHE leans toward sectors like Health Care. Meanwhile, ARKG focuses on Health Care.

What are the top holdings of the XHE ETF and ARKG ETF?

XHE top holdings include NEOGEN, INTEGER HOLDINGS and PENUMBRA. ARKG holds in its top three: CRISPR THERAPEUTICS, PERSONALIS INC and GUARDANT HEALTH INC.

Which ETF is more diversified: XHE or ARKG?

XHE holds 64 securities with 30.47% of its assets in the top 15. ARKG has 30 securities and a top 15 weight of 63.79%.

Advertisement
Latest news about XHE & ARKG
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast